Literature DB >> 6572372

A unitary mechanism of calcium antagonist drug action.

K M Murphy, R J Gould, B L Largent, S H Snyder.   

Abstract

[3H]Nitrendipine binding to drug receptor sites associated with calcium channels is allosterically regulated by a diverse group of calcium channel antagonists. Verapamil, D-600 (methoxyverapamil), tiapamil, lidoflazine, flunarizine, cinnarizine, and prenylamine all reduce [3H]nitrendipine binding affinity. By contrast, diltiazem, a benzothiazepine calcium channel antagonist, enhances [3H]nitrendipine binding. All these drug effects involve a single site allosterically linked to the [3H]nitrendipine binding site. Inhibition of [3H]nitrendipine binding by prenylamine, lidoflazine, or tiapamil is reversed by D-600 and diltiazem, which alone respectively slightly reduce or enhance [3H]nitrendipine binding. Diltiazem reverses the inhibition of [3H]nitrendipine binding by D-600. Our prediction that drugs allosterically regulating [3H]nitrendipine binding should be calcium antagonists is confirmed by calcium antagonism in guinea pig ileum observed with the antihistamine dimethindene, the neuroleptics thioridazine and mesoridazine, and the anticholinergic biperiden.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6572372      PMCID: PMC393480          DOI: 10.1073/pnas.80.3.860

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients.

Authors:  G Nyberg; R Axelsson; E Mårtensson
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

Review 2.  Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.

Authors:  A Fleckenstein
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

3.  The effect of Ca2+ antagonists on mechanical responses and Ca2+ movements in guinea pig ileal longitudinal smooth muscle.

Authors:  L B Rosenberger; M K Ticku; D J Triggle
Journal:  Can J Physiol Pharmacol       Date:  1979-04       Impact factor: 2.273

4.  Studies on a new 1,5-benzothiazepine derivative (CRD-401). IV. Coronary vasodilating effect and structure-activity relationship.

Authors:  T Nagao; M Sato; H Nakajima; A Kiyomoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1973-01       Impact factor: 1.645

5.  Serum levels of neuroleptics measured by dopamine radioreceptor assay and some clinical observations.

Authors:  H M Calil; D H Avery; L E Hollister; I Creese; S H Snyder
Journal:  Psychiatry Res       Date:  1979-07       Impact factor: 3.222

6.  Blockade of myocardial slow channels by bepridil (CERM-1978).

Authors:  S Vogel; R Crampton; N Sperelakis
Journal:  J Pharmacol Exp Ther       Date:  1979-09       Impact factor: 4.030

7.  Calcium antagonists and contractile responses in rat vas deferens and guinea pig ileal smooth muscle.

Authors:  C R Triggle; V C Swamy; D J Triggle
Journal:  Can J Physiol Pharmacol       Date:  1979-08       Impact factor: 2.273

8.  Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.

Authors:  R Eigenmann; L Blaber; K Nakamura; S Thorens; G Haeusler
Journal:  Arzneimittelforschung       Date:  1981

9.  Stereoselective and non-stereoselective effects of D 600 (methoxyverapamil) in smooth muscle preparations.

Authors:  K Jim; A Harris; L B Rosenberger; D J Triggle
Journal:  Eur J Pharmacol       Date:  1981-11-19       Impact factor: 4.432

Review 10.  Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem.

Authors:  P D Henry
Journal:  Am J Cardiol       Date:  1980-12-01       Impact factor: 2.778

View more
  33 in total

Review 1.  The purification of ion channels from excitable cells.

Authors:  J A Talvenheimo
Journal:  J Membr Biol       Date:  1985       Impact factor: 1.843

2.  Agonists Bay-K8644 and CGP-28392 open calcium channels reconstituted from skeletal muscle transverse tubules.

Authors:  H Affolter; R Coronado
Journal:  Biophys J       Date:  1985-08       Impact factor: 4.033

Review 3.  The molecular pharmacology and structural features of calcium channels.

Authors:  D R Ferry; A Goll; M Rombusch; H Glossmann
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

Review 4.  Calcium-channel blockers and anaesthesia.

Authors:  P G Durand; J J Lehot; P Foëx
Journal:  Can J Anaesth       Date:  1991-01       Impact factor: 5.063

5.  Differential antagonism by Bay k 8644, a dihydropyridine calcium agonist, of the negative inotropic effects of nifedipine, verapamil, diltiazem and manganese ions in canine ventricular muscle.

Authors:  K Ishii; N Taira; T Yanagisawa
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

6.  Inotropic effects of Ca2+ channel agonist and antagonists in neuraminidase-treated left atria of rats.

Authors:  Y Hattori; S Hazama; M Kanno; Y Nakao
Journal:  Br J Pharmacol       Date:  1986-02       Impact factor: 8.739

7.  Multiple voltage-sensitive calcium channels are probably involved in endogenous GABA release from striatal neurones differentiated in primary culture.

Authors:  J P Pin; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

8.  Interactions between a "calcium channel agonist", Bay K 8644, and calcium antagonists differentiate calcium antagonist subgroups in K+-depolarized smooth muscle.

Authors:  M Spedding; C Berg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-11       Impact factor: 3.000

9.  Cardiovascular effects of substituted tetrahydroisoquinolines in rats.

Authors:  H Dong; C M Lee; W L Huang; S X Peng
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

10.  Biochemical abnormalities in psychiatric outpatients.

Authors:  D G Lipman; J L Collins; C B Mathura; Z B Elder
Journal:  J Natl Med Assoc       Date:  1984-03       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.